TREATMENT SELECTION AND PRESCRIBING

The APRN Prescriber Role

Core concept: The nurse practitioner prescriber integrates advanced assessment, diagnosis, pharmacology, evidence, patient goals, and follow-up into a complete treatment plan. Prescribing requires advanced knowledge, clinical judgment, and clear prescription writing (Woo & Robinson, 2019).

Key clinical distinction: Registered nurses assess medication safety, administer therapy, educate patients, monitor response, and communicate concerns within their scope. Nurse practitioners also diagnose and prescribe within their role, population focus, competence, and jurisdictional authority (Minnesota Board of Nursing, n.d.; Woo & Robinson, 2019).

Prescribing priority: Every prescription requires a clear indication, an individualized benefit-harm assessment, complete directions, patient education, and a plan to evaluate effectiveness and safety.

Scope and Authority

  • APRN regulation differs by jurisdiction. Prescribers must know the statutes, rules, controlled-substance requirements, institutional policies, and payer restrictions that apply where the patient receives care.
  • A National Provider Identifier identifies the prescriber in standard health care transactions and is commonly required in electronic-prescribing, pharmacy, and payer workflows; it does not grant prescriptive authority. Prescribing controlled substances also requires applicable state authority and Drug Enforcement Administration registration (Knezevich et al., 2026; Minnesota Board of Nursing, n.d.).
  • Minnesota defines APRN practice to include advanced assessment, diagnosis, prescribing, and ordering. Licensed Minnesota APRNs may prescribe, dispense, and administer drugs, Schedule II through V controlled substances, and therapeutic devices within applicable scope and requirements (Minnesota Board of Nursing, n.d.).
  • Minnesota CNPs and CNSs beginning practice after July 1, 2014, complete at least 2,080 hours within a collaborative agreement. The state does not require a separate written prescribing agreement for these roles (Minnesota Board of Nursing, n.d.).
  • Legal authority establishes what a clinician may do. Education, certification, population focus, clinical competence, and the needs of the patient determine what the clinician should manage independently.

From Medication Administration to Prescribing

  • The RN evaluates whether an ordered medication can be administered safely, assesses relevant clinical data, identifies discrepancies, monitors response, provides education, and escalates concerns.
  • The NP determines whether medication is indicated, selects among treatment options, chooses the dose and regimen, writes the prescription, and establishes monitoring and follow-up.
  • The RN and NP roles overlap in medication reconciliation, patient education, adverse-effect recognition, adherence assessment, and evaluation of treatment response. The difference lies in diagnostic and prescribing authority, not in whether medication safety is a nursing responsibility.

Clinical Judgment Before Prescribing

  • Confirm the diagnosis or level of diagnostic uncertainty and determine whether medication is necessary.
  • Establish a therapeutic objective that can be evaluated.
  • Reconcile prescriptions, over-the-counter products, supplements, allergies, intolerances, previous treatment, and adherence.
  • Review age, pregnancy or lactation when relevant, kidney and liver function, comorbidities, interactions, genetic information, and risk for misuse or diversion.
  • Compare evidence, efficacy, adverse effects, monitoring burden, formulation, cost, access, and patient preference.
  • Know when the presentation, medication, or monitoring need exceeds current competence and requires consultation or referral.

Writing and Communicating the Plan

  • Use an unambiguous generic medication name when appropriate and specify strength, dosage form, route, dose, frequency, quantity or duration, refills, and indication when it improves safety.
  • A complete prescription order includes prescriber and patient identifying information, the date, the medication name, strength, and dose, directions to the patient, dispensing instructions for the pharmacist, the number of refills, and a generic-substitution instruction such as “DAW” (dispense as written) or “no substitution” when a brand-name product is required; specific wording requirements vary by state (Knezevich et al., 2026).
  • Controlled-substance prescriptions carry additional federal requirements, including the prescriber’s DEA number, and refill limits that vary by schedule: Schedule II prescriptions generally cannot be refilled, while Schedule III and IV prescriptions may be refilled up to five times within six months of the original order (Knezevich et al., 2026).
  • Electronic prescribing is now standard practice and is associated with fewer medication errors, better recognition of drug-drug and drug-disease interactions and allergy cross-sensitivity, and clearer visibility into patient adherence and insurance coverage. Recognized barriers include software cost and lack of standardization, training time, and clinician resistance during implementation (Knezevich et al., 2026).
  • Explain what the patient should start, continue, change, hold, or stop.
  • Document the indication, clinical reasoning, relevant contraindications and interactions considered, education, monitoring plan, and follow-up.
  • Review serious symptoms that require urgent evaluation and provide a clear contact plan for questions or adverse effects.

Monitoring and Accountability

  • Define expected benefit and possible harm before treatment begins. Monitoring should be specific enough that another clinician can identify what to assess and how the result will change management.
  • Review laboratory and diagnostic results within a defined workflow. Ordering a test without ensuring review and follow-up leaves the prescribing process incomplete.
  • Reassess continued indication during refills. A refill is a new prescribing decision, particularly when organ function, interacting medications, pregnancy status, disease control, or treatment goals may have changed.
  • Report serious adverse events or product problems through appropriate institutional and regulatory channels, including the FDA’s MedWatch program, the national voluntary reporting system for medication-related adverse events (Knezevich et al., 2026).

Collaboration

  • Pharmacists provide expertise in dosing, interactions, formulation, therapeutic drug monitoring, access, and medication-use systems.
  • Consultation with physicians, other APRNs, specialists, nurses, and other professionals strengthens care when diagnosis or treatment complexity exceeds one clinician’s expertise.
  • Effective collaboration requires a focused question, the relevant clinical data, and clear responsibility for follow-up.

Adherence and Access

  • Determine whether nonadherence is intentional, unintentional, or caused by access. Beliefs, adverse effects, cognitive or sensory limitations, regimen complexity, cost, pharmacy access, language, and competing needs require different responses.
  • Simplify the regimen when clinically appropriate. Match education to health literacy and use teach-back.
  • Ask directly whether the patient can obtain the medication and whether coverage restrictions or transportation will delay treatment.
  • Avoid documenting a patient as noncompliant without evaluating the reason the plan did not work.

Common Prescribing Errors

  • Prescribing before the problem and therapeutic objective are adequately defined.
  • Using error-prone abbreviations or ambiguous dose notation (such as “U” for units or a trailing zero after a decimal point) instead of writing prescriptions in complete, unambiguous language, and overlooking sound-alike or look-alike medication names (Knezevich et al., 2026).
  • Continuing a medication because it appears on the list without confirming indication, effectiveness, and current risk.
  • Relying on an electronic alert system as a substitute for medication reconciliation and clinical judgment.
  • Providing education without a monitoring and follow-up plan.
  • Practicing to the outer boundary of legal authority when the case exceeds current competence.
  • Failing to clarify who will review results, communicate changes, and manage refills.

Related YourDNP Resources

Content last reviewed:

References

Knezevich, E., Webb, C., & Knezevich, J. (2026). Prescription writing principles (Appendix A). In M. A. Chisholm-Burns, P. M. Malone, J. M. Kolesar, K. C. Lee, P. B. Bookstaver, & K. R. Matthias (Eds.), Pharmacotherapy principles & practice (7th ed.). McGraw Hill.

Minnesota Board of Nursing. (n.d.). Advanced Practice Registered Nurse (APRN) licensure general information. Retrieved September 10, 2026, from https://mn.gov/boards/nursing/advanced-practice/advanced-practice-registered-nurse-(aprn)-licensure-general-information/

Woo, T. M., & Robinson, M. V. (2019). The role of the advanced practice nurse practitioner as prescriber [PowerPoint slides]. F. A. Davis.